Mathieu Chicard
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 10
-
- Neuroblastoma Research and Treatments 4
- Co-authors
- Gudrun Schleiermacher (5 shared papers)Olivier Delattre (3 shared papers)Valérie Combaret (3 shared papers)Isabelle Janoueix‐Lerosey (2 shared papers)Virginie Bernard (2 shared papers)Angela Bellini (2 shared papers)Leo Colmet Daage (2 shared papers)Eve Lapouble (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)JCO Precision Oncology (2 papers)European Journal of Cancer (2 papers)International Journal of Cancer (2 papers)Epigenetics (1 paper)
- Partner nations
- FranceNetherlandsUnited Kingdom
In The Last Decade
Mathieu Chicard
15 papers receiving 1.1k citations
Mathieu Chicard's Hit Papers
Peers
Comparison fields: 5 of 51
- Neurology 442
- Cancer Research 417
- Pulmonary and Respiratory Medicine 125
- Genetics 35
- Molecular Biology 147
Countries citing papers authored by Mathieu Chicard
This map shows the geographic impact of Mathieu Chicard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Chicard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Chicard more than expected).
Fields of papers citing papers by Mathieu Chicard
This network shows the impact of papers produced by Mathieu Chicard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Chicard. The network helps show where Mathieu Chicard may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Chicard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations Hit paper breakdown → | 2015 | 436 |
| 2 | 2021 | 142 | |
| 3 | 2017 | 122 | |
| 4 | 2022 | 120 | |
| 5 | 2016 | 93 | |
| 6 | 2020 | 50 | |
| 7 | 2018 | 43 | |
| 8 | 2021 | 23 | |
| 9 | 2018 | 21 | |
| 10 | 2023 | 20 | |
| 11 | 2019 | 19 | |
| 12 | 2022 | 19 | |
| 13 | 2016 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2023 | 6 |
About Mathieu Chicard
Mathieu Chicard is a scholar working on Cancer Research, Neurology, Genetics, Pulmonary and Respiratory Medicine and Ophthalmology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Neuroblastoma Research and Treatments (4 papers), Sarcoma Diagnosis and Treatment (2 papers), Ocular Oncology and Treatments (1 paper), Genomic variations and chromosomal abnormalities (1 paper), Renal and related cancers (1 paper), Genomics and Chromatin Dynamics (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Neurology (442 citations), Cancer Research (417 citations), Pulmonary and Respiratory Medicine (125 citations), Genetics (35 citations) and Molecular Biology (147 citations). Mathieu Chicard has collaborated with scholars based in France, Netherlands and United Kingdom. Frequent co-authors include Gudrun Schleiermacher, Olivier Delattre, Valérie Combaret, Isabelle Janoueix‐Lerosey, Virginie Bernard, Angela Bellini, Leo Colmet Daage, Eve Lapouble, Nathalie Clément and Paul Deveau. Their work appears in journals such as Clinical Cancer Research, JCO Precision Oncology, European Journal of Cancer, International Journal of Cancer and Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.